Both patients with IPF and patients with PPF treated with nerandomilast demonstrated a smaller decline in forced vital capacity over 52 weeks versus placebo. In concurrent phase III FIBRONEER trials, patients with idiopathic pulmonary fibrosis...
Both patients with IPF and patients with PPF treated with nerandomilast demonstrated a smaller decline in forced vital capacity over 52 weeks versus placebo. In concurrent phase III FIBRONEER trials, patients with idiopathic pulmonary fibrosis...
Shifts in RSV testing methodology, which were accelerated by changes related to the COVID-19 pandemic, mirror shifts seen in RSV detection rates.
Both patients with IPF and patients with PPF treated with nerandomilast demonstrated a smaller decline in forced vital capacity over 52 weeks versus placebo.
Risk aversion to steroid side effects shaped treatment choices, underscoring support for tailored approaches in managing asthma attacks.
Expert consensus underscored the need for coordinated care in SEA with nasal polyps.
Endothelial dysfunction markers were linked to future disease activity and complications in lcSSc.
Shifts in RSV testing methodology, which were accelerated by changes related to the COVID-19 pandemic, mirror shifts seen in RSV detection rates.
Both patients with IPF and patients with PPF treated with nerandomilast demonstrated a smaller decline in forced vital capacity over 52 weeks versus placebo.
Risk aversion to steroid side effects shaped treatment choices, underscoring support for tailored approaches in managing asthma attacks.
Expert consensus underscored the need for coordinated care in SEA with nasal polyps.
Endothelial dysfunction markers were linked to future disease activity and complications in lcSSc.
A collection of feature articles, study abstracts, and other resources all focused COPD.
The latest news from ASCO 2024 focused on eNSCLC including abstracts, features, and helpful conference information.
Physician’s Weekly-created content featuring key opinion leaders sharing their perspectives on COPD and asthma from different vantage points.
Dr. Mark Sullivan discusses strategies for restoring the patient-physician relationship in response to the ongoing erosion of public trust in healthcare.
Despite mixed evidence, 75% of Americans take nutritional supplements, underlining the need for educated, open physician-patient dialogue regarding their use.
Dr. MedLaw explains the importance of discussing risks, benefits, and alternatives in a manner that patients fully understand when obtaining patient consent.
This course discusses a study that evaluated an alternative to the manovacuometer-assessed maximum inspiratory pressure test protocol based on the foundational elements of the one-repetition maximum test.
This course discusses a study that investigated outcomes and systemic measurements of inflammation resulting from antibiotic therapy in patients with cystic fibrosis who have experienced a pulmonary exacerbation.
This course discusses a study that aimed to identify criteria for palliative care referrals among patients with COPD.
Take a break for a little medicinal laughter with this week's medical...
Viewing this medical cartoon may enhance emotional vital signs, manifested by a smile or...
Today’s prescription: one medical cartoon; anticipated effect—elevated mood and occasional...
Claims denials increased by 60% in 2024, underscoring the urgent need for more accurate first-pass submissions through enhanced data and EHR utilization.
Nine states—and a dozen more soon—now allow internationally trained physicians to bypass full US residencies, seeking to mitigate rural physician shortages.
Smart billing automates claims, cuts errors, speeds payments, and boosts revenue—helping practices stay profitable and sustainable despite rising costs.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.